No abstract

Treatment of inflammatory bowel diseases IBD (Crohns disease, ulcerative colitis) is aimed at achieving clinical, endoscopic and histological remission, minimizing surgical complications, and ensuring a normal quality of life. However, the use of medical treatment is potentially associated with various adverse events, among which infectious complications, malignant neoplasms, as well as myelotoxicity, hepatotoxicity, skin lesions and others. The risk of side effects depends on the type of drug therapy (5-aminosalicylates, thiopurines, biologicals, etc.), the duration of treatment, the presence of extra-intestinal manifestations, etc. The article provides an overview of data on both the effectiveness and frequency of various side effects of the main classes of drugs in IBD, presents methods of investigation which can predict the effectiveness and development of side effects, the implementation of which can be considered as a variant of personalized therapy in IBD.

Diagnostics of hereditary spherocytosis is usually based on clinical picture, family history and laboratory tests. The list of laboratory tests includes osmotic fragility test, a glycerol lysis test, an eosin-5-maleimide binding test and others. None of the following methods identify all cases of hereditary spherocytosis. The article discusses the problems of diagnosing congenital microspherocytic anemia and provides the detailed analysis of informational value of various research methods and their significance.

Diagnosis of hereditary spherocytosis, as the most common form of membranopathy, is improved, thanks to advances in biotechnology and the presence of a large number of modern automatic analyzers. All this leads to a reduction in the number of patients with undiagnosed hereditary spherocytosis and a decrease in the incidence of complications. However, despite the improvement of various methods of evaluation of red blood cells, some difficulties in the diagnosis of hereditary spherocytosis remain. In this study, the authors developed an algorithm for the laboratory diagnosis of anemias microperimetry that will allow patients with high probability of hereditary spherocytosis differential diagnosis with other types of hemolytic anemia.

No abstract